{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:32:40Z","timestamp":1792006360604,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/007004"],"award-info":[{"award-number":["CRG\/2022\/007004"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bbadis.2024.167047","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T07:32:48Z","timestamp":1706513568000},"page":"167047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vildagliptin inhibits high fat and fetuin-A mediated DPP-4 expression, intracellular lipid accumulation and improves insulin secretory defects in pancreatic beta cells"],"prefix":"10.1016","volume":"1870","author":[{"given":"Snehasish","family":"Nag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanwita","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oindrila","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmay","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satinath","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167047_bb0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fimmu.2015.00386","article-title":"DPP4 in diabetes","volume":"6","author":"R\u00f6hrborn","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2023.01.070","article-title":"FFA-Fetuin-A regulates DPP-IV expression in pancreatic beta cells through TLR4-NFkB pathway","volume":"647","author":"Nag","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167047_bb0015","series-title":"DPP4\/CD32b\/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy","author":"Ming-Kuen Tang","year":"2021"},{"key":"10.1016\/j.bbadis.2024.167047_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ebiom.2019.01.065","article-title":"Oxidized LDL upregulates macrophage DPP4 expression via TLR4\/TRIF\/CD36 pathways","volume":"41","author":"Rao","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2024.167047_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122033","article-title":"Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review","volume":"8","author":"Bourebaba","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbadis.2024.167047_bb0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-Heremans-Schmid glycoprotein\/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2024.167047_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166050","article-title":"Increase in PPAR\u03b3 inhibitory phosphorylation by Fetuin\u2014a through the activation of Ras-MEK-ERK pathway causes insulin resistance","volume":"1867","author":"Das","year":"2021","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2024.167047_bb0040","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2024.167047_bb0045","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.258507","article-title":"Fetuin-A secretion from \u03b2-cells leads to accumulation of macrophages in islets, aggravates inflammation and impairs insulin secretion","volume":"134","author":"Mukhuty","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2024.167047_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.metabol.2015.10.002","article-title":"Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate","volume":"65","author":"Lee","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.bbadis.2024.167047_bb0055","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00125-013-2927-8","article-title":"Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model","volume":"56","author":"Omar","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2024.167047_bb0060","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.2337\/db16-0317","article-title":"DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1\/M2 macrophage polarization","volume":"65","author":"Zhuge","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2024.167047_bb0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1152\/ajpendo.00463.2010","article-title":"Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice","volume":"300","author":"Dobrian","year":"2011","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0070","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/dc13-0496","article-title":"Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro","volume":"36","author":"Sell","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2024.167047_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/db12-0230","article-title":"A potential role for dendritic cell\/macrophage-expressing DPP4 in obesity-induced visceral inflammation","volume":"62","author":"Zhong","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2024.167047_bb0080","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2024.167047_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-021-00644-5","article-title":"Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis","volume":"13","author":"Hattori","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bbadis.2024.167047_bb0090","first-page":"1845","article-title":"Potential effect of DPP-4 inhibitors towards hepatic diseases and associated glucose intolerance, diabetes","volume":"15","author":"Sharma","year":"2022","journal-title":"Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.bbadis.2024.167047_bb0095","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3803\/EnM.2022.605","article-title":"DPP-4 inhibitor in type 2 diabetes mellitus patient with non-alcoholic fatty liver disease: achieving two goals at once?","volume":"37","author":"Bae","year":"2022","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0100","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0105","article-title":"Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes","volume":"16","author":"Zhao","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2024.167047_bb0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bbrc.2016.03.015","article-title":"HMGA2 promotes adipogenesis by activating C\/EBP\u03b2-mediated expression of PPAR\u03b3","volume":"472","author":"Xi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167047_bb0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12272-016-0864-z","article-title":"Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models","volume":"40","author":"Kim","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bbadis.2024.167047_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21217815","article-title":"Linagliptin ameliorates hepatic steatosis via non-canonical mechanisms in mice treated with a dual inhibitor of insulin receptor and IGF-1 receptor","volume":"21","author":"Okuyama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167047_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173224","article-title":"Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats","volume":"881","author":"Aboulmagd","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4239\/wjd.v7.i19.534","article-title":"Linagliptin alleviates fatty liver disease in diabetic db\/db mice","volume":"7","author":"Michurina","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbadis.2024.167047_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038744","article-title":"Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity","volume":"7","author":"Kern","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2024.167047_bb0140","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1210\/jc.2014-3794","article-title":"Effect of vildagliptin on hepatic steatosis","volume":"100","author":"Macauley","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jcp.30499","article-title":"Fetuin-A excess expression amplifies lipid induced apoptosis and \u03b2-cell damage","volume":"237","author":"Mukhuty","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bbrc.2017.08.022","article-title":"Palmitate induced Fetuin-A secretion from pancreatic \u03b2-cells adversely affects its function and elicits inflammation","volume":"491","author":"Mukhuty","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167047_bb0155","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2024.167047_bb0160","first-page":"255","article-title":"Isolation, purification, and culture of mouse pancreatic islets of langerhans","volume":"2019","author":"Saliba","year":"1940","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0165","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1210\/en.2007-0387","article-title":"C-kit in early onset of diabetes: a morphological and functional analysis of pancreatic \u03b2-cells in c-KitW-v mutant mice","volume":"148","author":"Krishnamurthy","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2024.167047_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.2849","article-title":"Conditional \u03b21-integrin-deficient mice display impaired pancreatic \u03b2 cell function","volume":"224","author":"Riopel","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0175","first-page":"1613","article-title":"Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2","volume":"2014","author":"Wronkowitz","year":"1842","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2024.167047_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.prostaglandins.2006.06.006","article-title":"PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs","volume":"80","author":"Lim","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bbadis.2024.167047_bb0185","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1074\/jbc.271.12.7128","article-title":"SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I","volume":"271","author":"Streicher","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2024.167047_bb0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167047_bb0195","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2024.167047_bb0200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2147\/VHRM.S1707","article-title":"Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes","volume":"4","author":"Richter","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.bbadis.2024.167047_bb0205","first-page":"221","article-title":"GLUT2, glucose sensing and glucose homeostasis","author":"Thorens","year":"2014","journal-title":"Diabetol"},{"key":"10.1016\/j.bbadis.2024.167047_bb0210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S2213-8587(15)00482-9","article-title":"The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions","volume":"4","author":"Nauck","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2024.167047_bb0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.13129","article-title":"Incretin hormones: their role in health and disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0220","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jc.2011-0329","article-title":"Understanding the incretin effect","volume":"96","author":"Seino","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/iub.1709","article-title":"Significance of circulatory DPP4 activity in metabolic diseases","volume":"70","author":"Nargis","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2024.167047_bb0230","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2018.10.001","volume":"29","author":"Varin","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0235","doi-asserted-by":"crossref","first-page":"E2330","DOI":"10.1210\/jc.2014-1480","article-title":"Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and metabolic disorders study","volume":"99","author":"Zheng","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0240","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.numecd.2019.07.010","article-title":"Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus","volume":"29","author":"Barchetta","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bbadis.2024.167047_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16152720","article-title":"The role of DPP-4 inhibitors in the treatment algorithm of type 2 diabetes mellitus: when to select, what to expect","volume":"16","author":"Makrilakis","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbadis.2024.167047_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-020-0538-1","article-title":"Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbadis.2024.167047_bb0255","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3892\/br.2014.356","article-title":"Association between fetuin-A levels with insulin resistance and carotid intima-media thickness in patients with new-onset type 2 diabetes mellitus","volume":"2","author":"Yin","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.bbadis.2024.167047_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111314","article-title":"Blocking TLR4-NF-\u03baB pathway protects mouse islets from the combinatorial impact of high fat and fetuin-A mediated dysfunction and restores ability for insulin secretion","volume":"532","author":"Mukhuty","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0265","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2012-1544","article-title":"Sitagliptin exerts an antinflammatory action","volume":"97","author":"Makdissi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2024.167047_bb0270","first-page":"1","article-title":"Vildagliptin and its metabolite M20.7 induce the expression of S100A8 and S100A9 in human hepatoma HepG2 and leukemia HL-60 cells","volume":"6","author":"Asakura","year":"2016","journal-title":"Sci. Reports"},{"key":"10.1016\/j.bbadis.2024.167047_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00142","article-title":"Vildagliptin reduces stenosis of injured carotid artery in diabetic mouse through inhibiting vascular smooth muscle cell proliferation via ER stress\/NF-\u03baB pathway","volume":"10","author":"Ji","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0280","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.5114\/aoms.2019.86609","article-title":"Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats","volume":"17","author":"Zhang","year":"2021","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbadis.2024.167047_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.996716","article-title":"Lipid droplet accumulation in \u03b2 cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and \u03b2 cell dysfunction involving decreased insulin granules","volume":"13","author":"Horii","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2024.167047_bb0290","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4161\/isl.22720","article-title":"\u03b2-Cell metabolic alterations under chronic nutrient overload in rat and human islets","volume":"4","author":"Vernier","year":"2012","journal-title":"Islets"},{"key":"10.1016\/j.bbadis.2024.167047_bb0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.14037","article-title":"Connecting pancreatic islet lipid metabolism with insulin secretion and the development of type 2 diabetes","volume":"1461","author":"Imai","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2024.167047_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-2275(20)30159-0","article-title":"PPARadigms and PPARadoxes: expanding roles for PPAR\u03b3 in the control of lipid metabolism","volume":"43","author":"Walczak","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbadis.2024.167047_bb0305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jdiacomp.2012.03.013","article-title":"Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates \u03b2-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes","volume":"26","author":"Akarte","year":"2012","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.bbadis.2024.167047_bb0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.abb.2019.01.011","article-title":"Molecular and cellular regulation of human glucokinase","volume":"663","author":"Sternisha","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2024.167047_bb0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/diabetes.53.2.321","article-title":"Sterol regulatory element-binding protein-1 mediates the effect of insulin on hexokinase II gene expression in human muscle cells","volume":"53","author":"Gosmain","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2024.167047_bb0320","article-title":"Fetuin-A excess expression amplifies lipid induced apoptosis and \u03b2-cell damage","author":"Mukhuty","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2024.167047_bb0325","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.bbrc.2017.08.022","article-title":"Palmitate induced Fetuin-A secretion from pancreatic \u03b2-cells adversely affects its function and elicits inflammation","volume":"491","author":"Mukhuty","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392400036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392400036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:52:00Z","timestamp":1751215920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392400036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S092544392400036X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167047","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vildagliptin inhibits high fat and fetuin-A mediated DPP-4 expression, intracellular lipid accumulation and improves insulin secretory defects in pancreatic beta cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167047"}}